Home - Products - PI3K/Akt/mTOR signaling - PDK - 6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile

6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile

CAS No. 1207836-10-9

6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile( —— )

Catalog No. M37049 CAS No. 1207836-10-9

6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile is a PDK1 inhibitor with anticancer and antiproliferative activity that can be used to study angiosarcoma, adenocarcinoma, multiple myeloma, psoriasis, prostate cancer, and Alzheimer's disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 26 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile
  • Note
    Research use only, not for human use.
  • Brief Description
    6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile is a PDK1 inhibitor with anticancer and antiproliferative activity that can be used to study angiosarcoma, adenocarcinoma, multiple myeloma, psoriasis, prostate cancer, and Alzheimer's disease.
  • Description
    6-Bromo-4-methoxypyrazolo[1,5-a]pyridine-3-carbonitrile is a PDK1 inhibitor with anticancer and antiproliferative activity that can be used to study angiosarcoma, adenocarcinoma, multiple myeloma, psoriasis, prostate cancer, and Alzheimer's disease.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    PDK
  • Recptor
    PDK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1207836-10-9
  • Formula Weight
    252.07
  • Molecular Formula
    C9H6BrN3O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1cc(Br)cn2ncc(C#N)c12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Clodronate Disodium

    Clodronate Disodium, a bisphosphonate, is a potent antiosteolytic agent which inhibits bone resorption.

  • PDK1 inhibitor 7

    A potent, selective PDK1 inhibitor with IC50 of 1 nM.

  • KPLH1130

    KPLH1130 improves glucose tolerance in HFD-fed mice.?KPLH1130 is a specific pyruvate dehydrogenase kinase (PDK) inhibitor, blocks macrophage polarization and attenuates proinflammatory responses.